LakeShore Biopharma Co., Ltd. (LSBCF) › Shareholders' EquityLakeShore Biopharma Co., Ltd. (LSBCF) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2020: -847.32M CNY2021: -508.86M CNY2022: -698.97M CNY2023: 728.45M CNY2024: 585.21M CNY2025: 499.75M CNY499.75M CNY2020Shareholders' Equity (CNY)2025Fiscal YearShareholders' EquityChange YoY2025499.75M CNY-14.6%2024585.21M CNY-19.7%2023728.45M CNY+204.2%2022-698.97M CNY-37.4%2021-508.86M CNY+39.9%2020-847.32M CNY—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share